BioCentury
ARTICLE | Financial News

Illumina beats Street

July 24, 2013 12:52 AM UTC

Shares of Illumina Inc. (NASDAQ:ILMN) jumped 7% in early after-hours trading on Tuesday after the sequencing and microarray company announced 2Q13 earnings post-market that beat the Street. Revenues for the quarter were $346.1 million, up 23% from 2Q12 and beating the Street's estimate of $331.8 million. The company reported 2Q13 non-GAAP diluted EPS of $0.43, beating by $0.03 the Street's $0.40 estimate and the company's 2Q12 non-GAAP diluted EPS.

Illumina also raised its full year 2013 revenue guidance and said it now expects growth of 20%, up from the 15% growth it previously expected. The company also raised its full year 2013 non-GAAP diluted EPS guidance to $1.68-$1.72 from $1.55-$1.62. The Street was expecting 2013 revenues of $1.35 billion and full-year EPS of $1.67. Illumina reported 2012 revenues of $1.1 billion. ...